End-stage renal disease and erectile dysfunction. Is there any hope?
Ayub
W
W
Renal Unit, Walsgrave Hospital NHS Trust, Coventry, UK.
Fletcher
S
S
D000284:Administration, Oral; D000527:Alprostadil / Q000008:administration & dosage / Q000627:therapeutic use; D004864:Equipment and Supplies; D007172:Erectile Dysfunction / Q000209:etiology* / Q000503:physiopathology / Q000628:therapy*; D006801:Humans; D007676:Kidney Failure, Chronic / Q000150:complications*; D008297:Male; D015917:Penile Prosthesis; D010726:Phosphodiesterase Inhibitors / Q000008:administration & dosage / Q000627:therapeutic use; D010879:Piperazines / Q000008:administration & dosage / Q000627:therapeutic use; D011687:Purines; D000068677:Sildenafil Citrate; D013450:Sulfones; D014618:Vacuum; D014665:Vasodilator Agents / Q000008:administration & dosage / Q000627:therapeutic use
D010726:Phosphodiesterase Inhibitors; D010879:Piperazines; D011687:Purines; D013450:Sulfones; D014665:Vasodilator Agents; D000068677:Sildenafil Citrate; D000527:Alprostadil